CYG
EW icon

Clean Yield Group’s Edwards Lifesciences EW Stock Holding History

Clean Yield Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.1K Sell
1,000
-10
-1% -$824 0.02% 197
2025
Q4 		$86.1K Hold
1,010
– – 0.02% 188
2025
Q3 		$78.5K Hold
1,010
– – 0.02% 195
2025
Q2 		$79K Hold
1,010
– – 0.02% 194
2025
Q1 		$73.2K Hold
1,010
– – 0.02% 199
2024
Q4 		$74.8K Buy
1,010
+986
+4,108% +$69K 0.02% 200
2024
Q3 		$1.58K Hold
24
– – ﹤0.01% 428
2024
Q2 		$2.22K Buy
+24
New +$2.13K ﹤0.01% 344

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Clean Yield Group's EW Position: Q1 2026 in Review

Clean Yield Group reduced its Edwards Lifesciences (EW) stake by 0.99% in Q1 2026, selling an estimated $824 and leaving 1,000 shares worth $80.1K. The position accounts for 0.02% of the portfolio, ranked #197.

Clean Yield Group first reported a position in EW in Q2 2024 and has held it in 8 quarters since. The position peaked at $86.1K in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Clean Yield Group held 1,000 shares of Edwards Lifesciences worth $80.1K as of Q1 2026.
  • Clean Yield Group sold 10 Edwards Lifesciences shares in Q1 2026, an estimated $824.
  • Edwards Lifesciences made up 0.02% of Clean Yield Group's portfolio in Q1 2026, its #197 holding.
  • Clean Yield Group first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
  • Clean Yield Group's Edwards Lifesciences position peaked at $86.1K in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.